Results 121 to 130 of about 5,033,139 (146)

The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and Scotland. [PDF]

Pharmacoecon Open
Wang X, Zhao F, Newby D, Gao L, Li S.
europepmc   +1 more source

Assessing Financial Toxicity in Cancer: A Global Systematic Review and Meta-Analysis Using an Asset Framework. [PDF]

Cancer Med
Kacker S, Najjar W, Stemme R, Samaha NL, Yenokyan G, Armache M, Hearn M, Dorris CS, Todsen T, De Almeida J, Fagan J, Mehanna H, Fakhry C, Gharzai LA, Gupta S, Ettman CK, Mady LJ.   +16 more
europepmc   +1 more source

Dementia incidence across countries: a sex-specific ecological analysis of cancer incidence. [PDF]

Future Sci OA
You W, Chang HR, Coventry B, Sahay A, Henneberg M.   +4 more
europepmc   +1 more source

Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets.

JAMA Health Forum
Wouters OJ, Denolle C, Wei J, Papanicolas I.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Purchasing Power Parity in Pakistan: Evidence from Fourier Unit Root Tests

Emerging Markets Finance and Trade, 2021
Muhammad Zakaria, Jun Wen
exaly  

A Fractional Cointegration Analysis of Purchasing Power Parity

Journal of Business and Economic Statistics, 1993
Yin-Wong Cheung, Kon S Lai
exaly  

Searching for stationarity: Purchasing power parity under the current float

Journal of International Economics, 1997
David Papell
exaly  

Confidence Intervals for Half-Life Deviations From Purchasing Power Parity

Journal of Business and Economic Statistics, 2005
Barbara Rossi
exaly